A

Agilent Technologies Inc
NYSEHEALTHCAREDIAGNOSTICS & RESEARCH

Key Statistics

Market Cap
$48.72B
P/E Ratio
34.15
EPS
$5.06
Beta
1.24
52W High
$174.77
52W Low
$108.14
50-Day MA
$148.01
200-Day MA
$131.93
Dividend Yield
0.59%
Profit Margin
19.50%
Forward P/E
23.87
PEG Ratio
1.36

About Agilent Technologies Inc

Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.

Official WebsiteUSAFY End: October

Fundamentals

Revenue (TTM)$7.37B
Gross Profit (TTM)$3.96B
EBITDA$2.08B
Operating Margin25.60%
Return on Equity21.00%
Return on Assets8.63%
Revenue/Share (TTM)$26.10
Book Value$26.11
Price-to-Book6.33
Price-to-Sales (TTM)6.61
EV/Revenue6.62
EV/EBITDA23.98
Quarterly Earnings Growth (YoY)8.50%
Quarterly Revenue Growth (YoY)8.10%
Shares Outstanding$281.97M
Float$280.96M
% Insiders0.20%
% Institutions95.49%

Historical Volatility

HV 10-Day
29.26%
HV 20-Day
33.42%
HV 30-Day
32.58%
HV 60-Day
29.35%
HV Rank
75.8%

Volatility is currently contracting

Analyst Ratings

Consensus ($175.43 target)
4
Strong Buy
12
Buy
6
Hold

Latest News

Lithium Miners News For The Month Of September 2026

China's lithium carbonate spot prices and spodumene spot prices were significantly lower the past month. Lithium market news - China's biggest lithium mine (CATL's Jianxiawo Mine) loses its license and is back on care and maintenance. Why has Benchmark flipped 2027 lithium from Surplus to Deficit? Lithium miner news - Ganfeng Lithium swings to profit in H1 2026 as revenue nearly triples. Tianqi Lithium's profit surges 49-fold in H1 as revenue soars 153%.

Seeking Alpha9/22/2026Neutral
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequencing.

Business Wire9/21/2026Neutral
Agilent Announces Cash Dividend of 25.5 Cents per Share

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on October 6, 2026, to all shareholders of record as of the close of business on October 28, 2026. The timing and amounts of future dividends are subject to the determination and approval of Agilent's board of directors. About Agilent Technologies Agilent Technologies, Inc. (NYSE: A) is a global leader in anal.

Business Wire9/16/2026Neutral
Agilent to Participate in J.P. Morgan U.S. All Stars Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference. The event is scheduled for 10 a.m. BST on Wednesday, Sept. 23, 2026, in London. A live audio webcast and replay of the presentation will be available through Agilent's Investor Relations website. About Agilent Technologies Agilent Technologies, Inc. (NYSE: A) is a global leader.

Business Wire9/10/2026Neutral
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, following FDA clearance. This launch underscores Agilent's ongoing commitment to digital pathology, broadening its portfolio to address the increasing demand for high-throughput solutions in clinical laboratories.Pathology laboratories continue to face increasing pressure to improve diagnostic efficiency.

Business Wire9/4/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on A and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/26/2026